Hybrid deep model for predicting anti-cancer drug efficacy in colorectal cancer patients

被引:0
|
作者
Karthikeyan, A. [1 ]
Jothilakshmi, S. [1 ]
Suthir, S. [2 ]
机构
[1] Annamalai Univ, Dept Informat Technol, Chidambaram 608002, Tamil Nadu, India
[2] Amrita Vishwa Vidyapeetham, Dept Comp Sci & Engn, Amrita Sch Comp, Chennai, Tamil Nadu, India
关键词
Drug efficacy prediction; Recursive Feature Elimination with Hybrid Machine Learning mechanism; Gini impurity; Updated Rectified Linear Unit-Deep Convolutional Neural Network; Colorectal Cancer;
D O I
10.3233/WEB-230260
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Cancers are genetically diversified, so anticancer treatments have different levels of efficacy on people due to genetic differences. The main objective of this work is to predict the anticancer drug efficiency for colorectal cancer patients to reduce the mortality rates and provides immune energy for the patients. This paper proposes a novel anti-cancer drug efficacy system in colorectal cancer patients. The input data gene is normalized with the Min-Max normalization technique that normalizes the data in distinct scales. Subsequently, proposes an improved entropy-based feature to evaluate the uncertainty distribution of data, in which it induces weight to overcome the issue of computational complexity. Along with this feature, a correlation-based feature and statistical features are also retrieved. Subsequently, proposes a Recursive Feature Elimination with Hybrid Machine Learning (RFEHML) mechanism for selecting the appropriate feature set by eliminating the recursive features with the aid of hybrid Machine Learning strategies that combine decision tree and logistic regression. Also, the Gini impurity is employed for ranking the feature and selecting the maximum importance score by eliminating the least acquired importance score. Further, proposes a hybrid model for predicting the drug efficiency with the trained feature set. The hybrid model comprises of Long Short-Term Memory (LSTM) and Updated Rectified Linear Unit-Deep Convolutional Neural Network (UReLU-DCNN) model, in which DCNN is modified by updating the activation function at the fully connected layer. Consequently, the learned feature predicts the drug efficacy of anti-cancer in colorectal cancer patients by determining whether the patient is a responder or non- responder of the drug. Finally, the performance of the proposed RFEHML model is compared with other traditional approaches. It is found that the developed method has higher accuracy for each learning percentage, with values of 60LP = 92.48%, 70LP = 94.28%, 80LP = 95.24%, and 90LP = 96.86%, respectively.
引用
收藏
页码:359 / 380
页数:22
相关论文
共 50 条
  • [21] The anti-cancer effects and mechanism of artesunate on colorectal cancer
    Li, Linna
    Yuan, Shoujun
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 69 - 69
  • [22] Anti-cancer Drug Targeting using Stimuli Sensitive Mesoporous Silica Nanoparticle in Colorectal Cancer
    Mainuddin, Anoop
    Kumar, Anoop
    Sharma, Anjana
    Sharma, Nitin
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (39) : 3071 - 3073
  • [23] Anti-cancer drug sensitivity in sinonasal squamous cancer
    Garcia-Inclan, Cristina
    Lopez, Fernando
    Potes-Ares, Sira
    Llorente, Jose L.
    Hermsen, Mario
    CELLULAR ONCOLOGY, 2012, 35 : S46 - S46
  • [24] Improvement of anti-cancer drug efficacy via thermosensitive hydrogel in peritoneal carcinomatosis in gastric cancer
    Han, Tae-Su
    Hur, Keun
    Choi, Boram
    Lee, Ji-Yeon
    Byeon, Sun-Ju
    Min, Jimin
    Yu, Jieun
    Cho, Jung-Kyo
    Hong, Jimin
    Lee, Hyuk-Joon
    Kong, Seong-Ho
    Kim, Woo-Ho
    Yanagihara, Kazuyoshi
    Song, Soo-Chang
    Yang, Han-Kwang
    ONCOTARGET, 2017, 8 (65) : 108848 - 108858
  • [25] Anti-Cancer Drug Delivery System
    Li Yan
    Huang Wei
    Huang Ping
    Zhu Xinyuan
    Yan Deyue
    PROGRESS IN CHEMISTRY, 2014, 26 (08) : 1395 - 1408
  • [26] Valproic acid as anti-cancer drug
    Michaelis, Martin
    Doerr, Hans Wilhelm
    Cinatl, Jindrich, Jr.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (33) : 3378 - 3393
  • [27] MACROMOLECULE ANTI-CANCER DRUG CONJUGATES
    KATO, Y
    HARA, T
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1983, 41 (12) : 1135 - 1142
  • [28] Mitosis as an anti-cancer drug target
    Anna-Leena Salmela
    Marko J. Kallio
    Chromosoma, 2013, 122 : 431 - 449
  • [29] FTORAFUR - NEW ANTI-CANCER DRUG
    BRENNER, H
    CHAITCHIK, S
    BRENNER, J
    DIGESTION, 1977, 16 (03) : 233 - 233
  • [30] CISPLATIN - NEW ANTI-CANCER DRUG
    ROZENCWEIG, M
    ABELE, R
    BEDOGNI, P
    KENIS, Y
    LOUVAIN MEDICAL, 1979, 98 (10): : 679 - 684